Outlook of IL-6 signaling blockade for COVID-19 pneumonia
Crossref DOI link: https://doi.org/10.1186/s41232-020-00134-7
Published Online: 2020-10-05
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hashizume, Misato
Text and Data Mining valid from 2020-10-05
Version of Record valid from 2020-10-05
Article History
Received: 28 June 2020
Accepted: 7 July 2020
First Online: 5 October 2020
Ethics approval and consent to participate
: Not applicable
: MH is an employee of Chugai Pharmaceutical Co., Ltd.